nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—TYMP—blood plasma—hepatitis B	0.0206	0.178	CbGeAlD
Capecitabine—DPYD—blood—hepatitis B	0.013	0.113	CbGeAlD
Capecitabine—CDA—blood—hepatitis B	0.0125	0.108	CbGeAlD
Capecitabine—DPYD—liver—hepatitis B	0.0102	0.0882	CbGeAlD
Capecitabine—CDA—liver—hepatitis B	0.0098	0.0848	CbGeAlD
Capecitabine—CYP2C9—blood plasma—hepatitis B	0.00771	0.0668	CbGeAlD
Capecitabine—DPYD—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.00765	0.113	CbGpPWpGaD
Capecitabine—TYMP—blood—hepatitis B	0.00754	0.0653	CbGeAlD
Capecitabine—CDA—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.00682	0.101	CbGpPWpGaD
Capecitabine—CES1—blood—hepatitis B	0.00651	0.0564	CbGeAlD
Capecitabine—TYMS—blood—hepatitis B	0.00647	0.0561	CbGeAlD
Capecitabine—TYMP—liver—hepatitis B	0.0059	0.0511	CbGeAlD
Capecitabine—TYMP—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.00545	0.0807	CbGpPWpGaD
Capecitabine—CES1—liver—hepatitis B	0.00509	0.0441	CbGeAlD
Capecitabine—TYMS—liver—hepatitis B	0.00506	0.0438	CbGeAlD
Capecitabine—Sepsis—Telbivudine—hepatitis B	0.00456	0.00559	CcSEcCtD
Capecitabine—Blood triglycerides increased—Lamivudine—hepatitis B	0.00452	0.00554	CcSEcCtD
Capecitabine—Bone marrow depression—Lamivudine—hepatitis B	0.00439	0.00538	CcSEcCtD
Capecitabine—Blood creatinine increased—Entecavir—hepatitis B	0.00435	0.00533	CcSEcCtD
Capecitabine—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00425	0.0052	CcSEcCtD
Capecitabine—Abdominal pain upper—Entecavir—hepatitis B	0.00425	0.0052	CcSEcCtD
Capecitabine—Hepatomegaly—Lamivudine—hepatitis B	0.00419	0.00513	CcSEcCtD
Capecitabine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00419	0.00513	CcSEcCtD
Capecitabine—Throat sore—Lamivudine—hepatitis B	0.00411	0.00503	CcSEcCtD
Capecitabine—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00408	0.00499	CcSEcCtD
Capecitabine—CES1—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.00402	0.0595	CbGpPWpGaD
Capecitabine—Renal impairment—Telbivudine—hepatitis B	0.00401	0.00491	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.004	0.0049	CcSEcCtD
Capecitabine—Pain in extremity—Telbivudine—hepatitis B	0.00382	0.00467	CcSEcCtD
Capecitabine—Hyperaesthesia—Lamivudine—hepatitis B	0.00378	0.00462	CcSEcCtD
Capecitabine—Migraine—Telbivudine—hepatitis B	0.00376	0.0046	CcSEcCtD
Capecitabine—Neutropenia—Entecavir—hepatitis B	0.00376	0.0046	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Entecavir—hepatitis B	0.00373	0.00457	CcSEcCtD
Capecitabine—Rhinorrhoea—Lamivudine—hepatitis B	0.00366	0.00448	CcSEcCtD
Capecitabine—Hyperglycaemia—Entecavir—hepatitis B	0.00362	0.00444	CcSEcCtD
Capecitabine—Dysphonia—Lamivudine—hepatitis B	0.0036	0.00441	CcSEcCtD
Capecitabine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00355	0.00434	CcSEcCtD
Capecitabine—Renal failure—Entecavir—hepatitis B	0.00352	0.00431	CcSEcCtD
Capecitabine—Abdominal pain upper—Telbivudine—hepatitis B	0.00349	0.00427	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00344	0.00421	CcSEcCtD
Capecitabine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00344	0.00421	CcSEcCtD
Capecitabine—Haematuria—Entecavir—hepatitis B	0.00342	0.00418	CcSEcCtD
Capecitabine—Nasopharyngitis—Telbivudine—hepatitis B	0.00341	0.00418	CcSEcCtD
Capecitabine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00341	0.00417	CcSEcCtD
Capecitabine—Hepatobiliary disease—Entecavir—hepatitis B	0.00339	0.00415	CcSEcCtD
Capecitabine—Gastritis—Telbivudine—hepatitis B	0.00338	0.00414	CcSEcCtD
Capecitabine—Muscular weakness—Telbivudine—hepatitis B	0.00337	0.00412	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00337	0.00412	CcSEcCtD
Capecitabine—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00333	0.00408	CcSEcCtD
Capecitabine—Abdominal distension—Telbivudine—hepatitis B	0.00332	0.00407	CcSEcCtD
Capecitabine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00331	0.00405	CcSEcCtD
Capecitabine—Influenza—Telbivudine—hepatitis B	0.0033	0.00404	CcSEcCtD
Capecitabine—Rectal haemorrhage—Lamivudine—hepatitis B	0.00328	0.00402	CcSEcCtD
Capecitabine—Oropharyngeal pain—Lamivudine—hepatitis B	0.00326	0.00399	CcSEcCtD
Capecitabine—Hepatitis—Entecavir—hepatitis B	0.00322	0.00394	CcSEcCtD
Capecitabine—Oedema peripheral—Entecavir—hepatitis B	0.00317	0.00388	CcSEcCtD
Capecitabine—Abdominal discomfort—Telbivudine—hepatitis B	0.00316	0.00387	CcSEcCtD
Capecitabine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00314	0.00384	CcSEcCtD
Capecitabine—Hearing impaired—Lamivudine—hepatitis B	0.00311	0.00381	CcSEcCtD
Capecitabine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00311	0.00381	CcSEcCtD
Capecitabine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0031	0.00379	CcSEcCtD
Capecitabine—Neutropenia—Telbivudine—hepatitis B	0.00309	0.00378	CcSEcCtD
Capecitabine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00308	0.00377	CcSEcCtD
Capecitabine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00308	0.00376	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00307	0.00375	CcSEcCtD
Capecitabine—Inflammation—Lamivudine—hepatitis B	0.00306	0.00374	CcSEcCtD
Capecitabine—Immune system disorder—Entecavir—hepatitis B	0.0029	0.00356	CcSEcCtD
Capecitabine—Renal failure—Telbivudine—hepatitis B	0.00289	0.00354	CcSEcCtD
Capecitabine—Neuropathy peripheral—Telbivudine—hepatitis B	0.00288	0.00353	CcSEcCtD
Capecitabine—Alopecia—Entecavir—hepatitis B	0.00284	0.00348	CcSEcCtD
Capecitabine—CYP2C9—blood—hepatitis B	0.00283	0.0245	CbGeAlD
Capecitabine—Mental disorder—Entecavir—hepatitis B	0.00282	0.00345	CcSEcCtD
Capecitabine—Malnutrition—Entecavir—hepatitis B	0.0028	0.00343	CcSEcCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.00279	0.0413	CbGpPWpGaD
Capecitabine—Neuropathy—Lamivudine—hepatitis B	0.00278	0.00341	CcSEcCtD
Capecitabine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00278	0.00341	CcSEcCtD
Capecitabine—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00273	0.00334	CcSEcCtD
Capecitabine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00269	0.00329	CcSEcCtD
Capecitabine—Urine output increased—Lamivudine—hepatitis B	0.00268	0.00328	CcSEcCtD
Capecitabine—Mouth ulceration—Lamivudine—hepatitis B	0.00268	0.00328	CcSEcCtD
Capecitabine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00264	0.00323	CcSEcCtD
Capecitabine—Hepatitis—Telbivudine—hepatitis B	0.00264	0.00323	CcSEcCtD
Capecitabine—Hypoaesthesia—Telbivudine—hepatitis B	0.00263	0.00322	CcSEcCtD
Capecitabine—Pharyngitis—Telbivudine—hepatitis B	0.00262	0.00321	CcSEcCtD
Capecitabine—Connective tissue disorder—Telbivudine—hepatitis B	0.0026	0.00318	CcSEcCtD
Capecitabine—Sepsis—Lamivudine—hepatitis B	0.00257	0.00315	CcSEcCtD
Capecitabine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00252	0.00309	CcSEcCtD
Capecitabine—Leukopenia—Entecavir—hepatitis B	0.00251	0.00307	CcSEcCtD
Capecitabine—Phlebitis—Lamivudine—hepatitis B	0.0025	0.00306	CcSEcCtD
Capecitabine—Sleep disorder—Lamivudine—hepatitis B	0.00249	0.00304	CcSEcCtD
Capecitabine—Polyuria—Lamivudine—hepatitis B	0.00245	0.003	CcSEcCtD
Capecitabine—Gastroenteritis—Lamivudine—hepatitis B	0.00243	0.00297	CcSEcCtD
Capecitabine—Deafness—Lamivudine—hepatitis B	0.00241	0.00294	CcSEcCtD
Capecitabine—Cough—Adefovir Dipivoxil—hepatitis B	0.00238	0.00292	CcSEcCtD
Capecitabine—Mediastinal disorder—Telbivudine—hepatitis B	0.00238	0.00291	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00237	0.0029	CcSEcCtD
Capecitabine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00233	0.00285	CcSEcCtD
Capecitabine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00233	0.00285	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00231	0.00283	CcSEcCtD
Capecitabine—Malnutrition—Telbivudine—hepatitis B	0.0023	0.00281	CcSEcCtD
Capecitabine—Infection—Entecavir—hepatitis B	0.00227	0.00278	CcSEcCtD
Capecitabine—Renal impairment—Lamivudine—hepatitis B	0.00226	0.00277	CcSEcCtD
Capecitabine—Thirst—Lamivudine—hepatitis B	0.00226	0.00277	CcSEcCtD
Capecitabine—Dysgeusia—Telbivudine—hepatitis B	0.00225	0.00276	CcSEcCtD
Capecitabine—Nervous system disorder—Entecavir—hepatitis B	0.00224	0.00274	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—CDKN2A—hepatitis B	0.00223	0.033	CbGpPWpGaD
Capecitabine—Back pain—Telbivudine—hepatitis B	0.00222	0.00272	CcSEcCtD
Capecitabine—Skin disorder—Entecavir—hepatitis B	0.00222	0.00272	CcSEcCtD
Capecitabine—Muscle spasms—Telbivudine—hepatitis B	0.00221	0.00271	CcSEcCtD
Capecitabine—CYP2C9—liver—hepatitis B	0.00221	0.0191	CbGeAlD
Capecitabine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00219	0.00268	CcSEcCtD
Capecitabine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00218	0.00267	CcSEcCtD
Capecitabine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00217	0.00265	CcSEcCtD
Capecitabine—Ill-defined disorder—Telbivudine—hepatitis B	0.00213	0.00261	CcSEcCtD
Capecitabine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00212	0.0026	CcSEcCtD
Capecitabine—Migraine—Lamivudine—hepatitis B	0.00212	0.00259	CcSEcCtD
Capecitabine—Malaise—Telbivudine—hepatitis B	0.00207	0.00254	CcSEcCtD
Capecitabine—Insomnia—Entecavir—hepatitis B	0.00207	0.00253	CcSEcCtD
Capecitabine—Mood swings—Lamivudine—hepatitis B	0.00204	0.0025	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00203	0.00249	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—GGT2—hepatitis B	0.00202	0.0299	CbGpPWpGaD
Capecitabine—Dyspepsia—Entecavir—hepatitis B	0.00201	0.00246	CcSEcCtD
Capecitabine—Cough—Telbivudine—hepatitis B	0.00201	0.00246	CcSEcCtD
Capecitabine—Dehydration—Lamivudine—hepatitis B	0.002	0.00245	CcSEcCtD
Capecitabine—Liver function test abnormal—Lamivudine—hepatitis B	0.00199	0.00243	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00197	0.00241	CcSEcCtD
Capecitabine—Fatigue—Entecavir—hepatitis B	0.00197	0.00241	CcSEcCtD
Capecitabine—Abdominal pain upper—Lamivudine—hepatitis B	0.00197	0.00241	CcSEcCtD
Capecitabine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00196	0.0024	CcSEcCtD
Capecitabine—Arthralgia—Telbivudine—hepatitis B	0.00196	0.0024	CcSEcCtD
Capecitabine—Chest pain—Telbivudine—hepatitis B	0.00196	0.0024	CcSEcCtD
Capecitabine—Myalgia—Telbivudine—hepatitis B	0.00196	0.0024	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00194	0.00238	CcSEcCtD
Capecitabine—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00194	0.00237	CcSEcCtD
Capecitabine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00194	0.00237	CcSEcCtD
Capecitabine—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00194	0.0287	CbGpPWpGaD
Capecitabine—Discomfort—Telbivudine—hepatitis B	0.00193	0.00237	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00192	0.00236	CcSEcCtD
Capecitabine—Nasopharyngitis—Lamivudine—hepatitis B	0.00192	0.00236	CcSEcCtD
Capecitabine—Muscular weakness—Lamivudine—hepatitis B	0.0019	0.00232	CcSEcCtD
Capecitabine—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.0019	0.00232	CcSEcCtD
Capecitabine—Abdominal distension—Lamivudine—hepatitis B	0.00187	0.00229	CcSEcCtD
Capecitabine—Gastrointestinal pain—Entecavir—hepatitis B	0.00187	0.00229	CcSEcCtD
Capecitabine—Influenza—Lamivudine—hepatitis B	0.00186	0.00228	CcSEcCtD
Capecitabine—Dysphagia—Lamivudine—hepatitis B	0.00186	0.00228	CcSEcCtD
Capecitabine—Nervous system disorder—Telbivudine—hepatitis B	0.00184	0.00225	CcSEcCtD
Capecitabine—Thrombocytopenia—Telbivudine—hepatitis B	0.00184	0.00225	CcSEcCtD
Capecitabine—Skin disorder—Telbivudine—hepatitis B	0.00182	0.00223	CcSEcCtD
Capecitabine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00182	0.00223	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—CDKN1A—hepatitis B	0.00182	0.0269	CbGpPWpGaD
Capecitabine—Sweating increased—Lamivudine—hepatitis B	0.00181	0.00222	CcSEcCtD
Capecitabine—Body temperature increased—Entecavir—hepatitis B	0.00181	0.00221	CcSEcCtD
Capecitabine—Abdominal pain—Entecavir—hepatitis B	0.00181	0.00221	CcSEcCtD
Capecitabine—Bronchitis—Lamivudine—hepatitis B	0.00179	0.00219	CcSEcCtD
Capecitabine—Abdominal discomfort—Lamivudine—hepatitis B	0.00178	0.00218	CcSEcCtD
Capecitabine—Pancytopenia—Lamivudine—hepatitis B	0.00177	0.00216	CcSEcCtD
Capecitabine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00176	0.00216	CcSEcCtD
Capecitabine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00176	0.00216	CcSEcCtD
Capecitabine—Dysuria—Lamivudine—hepatitis B	0.00174	0.00213	CcSEcCtD
Capecitabine—Neutropenia—Lamivudine—hepatitis B	0.00174	0.00213	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00171	0.00209	CcSEcCtD
Capecitabine—Insomnia—Telbivudine—hepatitis B	0.0017	0.00208	CcSEcCtD
Capecitabine—Paraesthesia—Telbivudine—hepatitis B	0.00169	0.00206	CcSEcCtD
Capecitabine—Hyperglycaemia—Lamivudine—hepatitis B	0.00168	0.00205	CcSEcCtD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—hepatitis B	0.00165	0.0245	CbGpPWpGaD
Capecitabine—Depression—Lamivudine—hepatitis B	0.00165	0.00202	CcSEcCtD
Capecitabine—Dyspepsia—Telbivudine—hepatitis B	0.00165	0.00202	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00164	0.00201	CcSEcCtD
Capecitabine—Asthenia—Entecavir—hepatitis B	0.00164	0.00201	CcSEcCtD
Capecitabine—Renal failure—Lamivudine—hepatitis B	0.00163	0.002	CcSEcCtD
Capecitabine—Neuropathy peripheral—Lamivudine—hepatitis B	0.00163	0.00199	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00162	0.00198	CcSEcCtD
Capecitabine—Fatigue—Telbivudine—hepatitis B	0.00162	0.00198	CcSEcCtD
Capecitabine—Stomatitis—Lamivudine—hepatitis B	0.00162	0.00198	CcSEcCtD
Capecitabine—Jaundice—Lamivudine—hepatitis B	0.00162	0.00198	CcSEcCtD
Capecitabine—Pain—Telbivudine—hepatitis B	0.0016	0.00196	CcSEcCtD
Capecitabine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0016	0.00196	CcSEcCtD
Capecitabine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00158	0.00193	CcSEcCtD
Capecitabine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00157	0.00192	CcSEcCtD
Capecitabine—Epistaxis—Lamivudine—hepatitis B	0.00156	0.00191	CcSEcCtD
Capecitabine—Diarrhoea—Entecavir—hepatitis B	0.00156	0.00191	CcSEcCtD
Capecitabine—Agranulocytosis—Lamivudine—hepatitis B	0.00155	0.00189	CcSEcCtD
Capecitabine—Feeling abnormal—Telbivudine—hepatitis B	0.00155	0.00189	CcSEcCtD
Capecitabine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00153	0.00188	CcSEcCtD
Capecitabine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00153	0.00187	CcSEcCtD
Capecitabine—Dizziness—Entecavir—hepatitis B	0.00151	0.00185	CcSEcCtD
Capecitabine—Rhinitis—Lamivudine—hepatitis B	0.00149	0.00183	CcSEcCtD
Capecitabine—Hepatitis—Lamivudine—hepatitis B	0.00149	0.00182	CcSEcCtD
Capecitabine—Body temperature increased—Telbivudine—hepatitis B	0.00148	0.00182	CcSEcCtD
Capecitabine—Abdominal pain—Telbivudine—hepatitis B	0.00148	0.00182	CcSEcCtD
Capecitabine—Hypoaesthesia—Lamivudine—hepatitis B	0.00148	0.00181	CcSEcCtD
Capecitabine—Pharyngitis—Lamivudine—hepatitis B	0.00148	0.00181	CcSEcCtD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—hepatitis B	0.00147	0.0218	CbGpPWpGaD
Capecitabine—Connective tissue disorder—Lamivudine—hepatitis B	0.00146	0.00179	CcSEcCtD
Capecitabine—Vomiting—Entecavir—hepatitis B	0.00145	0.00178	CcSEcCtD
Capecitabine—Rash—Entecavir—hepatitis B	0.00144	0.00176	CcSEcCtD
Capecitabine—Dermatitis—Entecavir—hepatitis B	0.00144	0.00176	CcSEcCtD
Capecitabine—Headache—Entecavir—hepatitis B	0.00143	0.00175	CcSEcCtD
Capecitabine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00142	0.00173	CcSEcCtD
Capecitabine—Erythema multiforme—Lamivudine—hepatitis B	0.00141	0.00172	CcSEcCtD
Capecitabine—Rash—Adefovir Dipivoxil—hepatitis B	0.00141	0.00172	CcSEcCtD
Capecitabine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0014	0.00172	CcSEcCtD
Capecitabine—Headache—Adefovir Dipivoxil—hepatitis B	0.0014	0.00171	CcSEcCtD
Capecitabine—Nausea—Entecavir—hepatitis B	0.00136	0.00166	CcSEcCtD
Capecitabine—Asthenia—Telbivudine—hepatitis B	0.00135	0.00165	CcSEcCtD
Capecitabine—Immune system disorder—Lamivudine—hepatitis B	0.00134	0.00165	CcSEcCtD
Capecitabine—Mediastinal disorder—Lamivudine—hepatitis B	0.00134	0.00164	CcSEcCtD
Capecitabine—Chills—Lamivudine—hepatitis B	0.00134	0.00164	CcSEcCtD
Capecitabine—Pruritus—Telbivudine—hepatitis B	0.00133	0.00163	CcSEcCtD
Capecitabine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00132	0.00162	CcSEcCtD
Capecitabine—Alopecia—Lamivudine—hepatitis B	0.00132	0.00161	CcSEcCtD
Capecitabine—Erythema—Lamivudine—hepatitis B	0.0013	0.00159	CcSEcCtD
Capecitabine—Malnutrition—Lamivudine—hepatitis B	0.0013	0.00159	CcSEcCtD
Capecitabine—Diarrhoea—Telbivudine—hepatitis B	0.00128	0.00157	CcSEcCtD
Capecitabine—Flatulence—Lamivudine—hepatitis B	0.00128	0.00156	CcSEcCtD
Capecitabine—Dysgeusia—Lamivudine—hepatitis B	0.00127	0.00155	CcSEcCtD
Capecitabine—Back pain—Lamivudine—hepatitis B	0.00125	0.00153	CcSEcCtD
Capecitabine—Muscle spasms—Lamivudine—hepatitis B	0.00125	0.00153	CcSEcCtD
Capecitabine—Dizziness—Telbivudine—hepatitis B	0.00124	0.00152	CcSEcCtD
Capecitabine—TYMP—Bladder Cancer—TP53—hepatitis B	0.00124	0.0183	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—CYP2A6—hepatitis B	0.00122	0.0181	CbGpPWpGaD
Capecitabine—Tremor—Lamivudine—hepatitis B	0.00121	0.00149	CcSEcCtD
Capecitabine—Ill-defined disorder—Lamivudine—hepatitis B	0.0012	0.00147	CcSEcCtD
Capecitabine—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.0012	0.0178	CbGpPWpGaD
Capecitabine—Anaemia—Lamivudine—hepatitis B	0.0012	0.00147	CcSEcCtD
Capecitabine—Vomiting—Telbivudine—hepatitis B	0.00119	0.00146	CcSEcCtD
Capecitabine—Rash—Telbivudine—hepatitis B	0.00118	0.00145	CcSEcCtD
Capecitabine—Dermatitis—Telbivudine—hepatitis B	0.00118	0.00145	CcSEcCtD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—hepatitis B	0.00118	0.0174	CbGpPWpGaD
Capecitabine—Headache—Telbivudine—hepatitis B	0.00118	0.00144	CcSEcCtD
Capecitabine—Malaise—Lamivudine—hepatitis B	0.00117	0.00143	CcSEcCtD
Capecitabine—Vertigo—Lamivudine—hepatitis B	0.00116	0.00143	CcSEcCtD
Capecitabine—Syncope—Lamivudine—hepatitis B	0.00116	0.00142	CcSEcCtD
Capecitabine—Leukopenia—Lamivudine—hepatitis B	0.00116	0.00142	CcSEcCtD
Capecitabine—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00115	0.0171	CbGpPWpGaD
Capecitabine—Loss of consciousness—Lamivudine—hepatitis B	0.00114	0.00139	CcSEcCtD
Capecitabine—Cough—Lamivudine—hepatitis B	0.00113	0.00138	CcSEcCtD
Capecitabine—Nausea—Telbivudine—hepatitis B	0.00111	0.00136	CcSEcCtD
Capecitabine—Chest pain—Lamivudine—hepatitis B	0.0011	0.00135	CcSEcCtD
Capecitabine—Arthralgia—Lamivudine—hepatitis B	0.0011	0.00135	CcSEcCtD
Capecitabine—Myalgia—Lamivudine—hepatitis B	0.0011	0.00135	CcSEcCtD
Capecitabine—Anxiety—Lamivudine—hepatitis B	0.0011	0.00135	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.0011	0.00134	CcSEcCtD
Capecitabine—Discomfort—Lamivudine—hepatitis B	0.00109	0.00133	CcSEcCtD
Capecitabine—Dry mouth—Lamivudine—hepatitis B	0.00108	0.00132	CcSEcCtD
Capecitabine—Confusional state—Lamivudine—hepatitis B	0.00107	0.00131	CcSEcCtD
Capecitabine—Oedema—Lamivudine—hepatitis B	0.00106	0.00129	CcSEcCtD
Capecitabine—Infection—Lamivudine—hepatitis B	0.00105	0.00129	CcSEcCtD
Capecitabine—Shock—Lamivudine—hepatitis B	0.00104	0.00127	CcSEcCtD
Capecitabine—Nervous system disorder—Lamivudine—hepatitis B	0.00104	0.00127	CcSEcCtD
Capecitabine—Thrombocytopenia—Lamivudine—hepatitis B	0.00104	0.00127	CcSEcCtD
Capecitabine—Skin disorder—Lamivudine—hepatitis B	0.00103	0.00126	CcSEcCtD
Capecitabine—Hyperhidrosis—Lamivudine—hepatitis B	0.00102	0.00125	CcSEcCtD
Capecitabine—Anorexia—Lamivudine—hepatitis B	0.00101	0.00123	CcSEcCtD
Capecitabine—Hypotension—Lamivudine—hepatitis B	0.000988	0.00121	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000964	0.00118	CcSEcCtD
Capecitabine—Insomnia—Lamivudine—hepatitis B	0.000957	0.00117	CcSEcCtD
Capecitabine—CES1—NRF2 pathway—GGT1—hepatitis B	0.000955	0.0141	CbGpPWpGaD
Capecitabine—Paraesthesia—Lamivudine—hepatitis B	0.00095	0.00116	CcSEcCtD
Capecitabine—Dyspnoea—Lamivudine—hepatitis B	0.000943	0.00115	CcSEcCtD
Capecitabine—Dyspepsia—Lamivudine—hepatitis B	0.000931	0.00114	CcSEcCtD
Capecitabine—Decreased appetite—Lamivudine—hepatitis B	0.000919	0.00113	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000913	0.00112	CcSEcCtD
Capecitabine—Fatigue—Lamivudine—hepatitis B	0.000912	0.00112	CcSEcCtD
Capecitabine—Pain—Lamivudine—hepatitis B	0.000904	0.00111	CcSEcCtD
Capecitabine—Constipation—Lamivudine—hepatitis B	0.000904	0.00111	CcSEcCtD
Capecitabine—Feeling abnormal—Lamivudine—hepatitis B	0.000872	0.00107	CcSEcCtD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—hepatitis B	0.000869	0.0129	CbGpPWpGaD
Capecitabine—Gastrointestinal pain—Lamivudine—hepatitis B	0.000865	0.00106	CcSEcCtD
Capecitabine—Urticaria—Lamivudine—hepatitis B	0.00084	0.00103	CcSEcCtD
Capecitabine—Body temperature increased—Lamivudine—hepatitis B	0.000836	0.00102	CcSEcCtD
Capecitabine—Abdominal pain—Lamivudine—hepatitis B	0.000836	0.00102	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—CDKN2A—hepatitis B	0.000828	0.0122	CbGpPWpGaD
Capecitabine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000824	0.0122	CbGpPWpGaD
Capecitabine—Hypersensitivity—Lamivudine—hepatitis B	0.000779	0.000954	CcSEcCtD
Capecitabine—Asthenia—Lamivudine—hepatitis B	0.000759	0.000929	CcSEcCtD
Capecitabine—Pruritus—Lamivudine—hepatitis B	0.000748	0.000916	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000728	0.0108	CbGpPWpGaD
Capecitabine—Diarrhoea—Lamivudine—hepatitis B	0.000724	0.000886	CcSEcCtD
Capecitabine—Dizziness—Lamivudine—hepatitis B	0.000699	0.000856	CcSEcCtD
Capecitabine—CES1—E2F transcription factor network—CDKN1A—hepatitis B	0.000676	0.01	CbGpPWpGaD
Capecitabine—Vomiting—Lamivudine—hepatitis B	0.000672	0.000823	CcSEcCtD
Capecitabine—Rash—Lamivudine—hepatitis B	0.000667	0.000816	CcSEcCtD
Capecitabine—Dermatitis—Lamivudine—hepatitis B	0.000666	0.000816	CcSEcCtD
Capecitabine—Headache—Lamivudine—hepatitis B	0.000663	0.000811	CcSEcCtD
Capecitabine—Nausea—Lamivudine—hepatitis B	0.000628	0.000769	CcSEcCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—hepatitis B	0.000603	0.00893	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKR1B1—hepatitis B	0.000601	0.0089	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GGT2—hepatitis B	0.000577	0.00853	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—hepatitis B	0.000574	0.0085	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKR1B1—hepatitis B	0.000536	0.00793	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GGT2—hepatitis B	0.000514	0.00761	CbGpPWpGaD
Capecitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000498	0.00738	CbGpPWpGaD
Capecitabine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000492	0.00728	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN1A—hepatitis B	0.000469	0.00695	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.00045	0.00666	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKR1B1—hepatitis B	0.000429	0.00634	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GGT2—hepatitis B	0.000411	0.00608	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00041	0.00607	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—hepatitis B	0.000408	0.00604	CbGpPWpGaD
Capecitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000404	0.00598	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000396	0.00585	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—FAS—hepatitis B	0.00038	0.00562	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000364	0.00539	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000354	0.00524	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—hepatitis B	0.000351	0.0052	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CYP2A6—hepatitis B	0.000349	0.00517	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—CDKN1A—hepatitis B	0.000341	0.00504	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NOS2—hepatitis B	0.000325	0.00481	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFB1—hepatitis B	0.000321	0.00475	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GOT2—hepatitis B	0.000316	0.00468	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CYP2A6—hepatitis B	0.000311	0.00461	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN1A—hepatitis B	0.000287	0.00425	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GOT2—hepatitis B	0.000282	0.00417	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—hepatitis B	0.000278	0.00411	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GOT1—hepatitis B	0.000273	0.00404	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GGT1—hepatitis B	0.000273	0.00404	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP2A6—hepatitis B	0.000249	0.00368	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GOT1—hepatitis B	0.000243	0.0036	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GGT1—hepatitis B	0.000243	0.0036	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GOT2—hepatitis B	0.000225	0.00333	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000223	0.00329	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKR1B1—hepatitis B	0.000219	0.00324	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000217	0.00322	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000217	0.00321	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000216	0.00319	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000215	0.00318	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GGT2—hepatitis B	0.00021	0.00311	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PTEN—hepatitis B	0.000208	0.00308	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GOT1—hepatitis B	0.000194	0.00288	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GGT1—hepatitis B	0.000194	0.00288	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.00018	0.00266	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000168	0.00248	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000168	0.00248	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000148	0.00219	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALB—hepatitis B	0.000145	0.00215	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TP53—hepatitis B	0.000142	0.0021	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000142	0.0021	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—hepatitis B	0.00013	0.00193	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—hepatitis B	0.000129	0.00191	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—hepatitis B	0.000129	0.00191	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP2A6—hepatitis B	0.000127	0.00188	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GOT2—hepatitis B	0.000115	0.0017	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN2A—hepatitis B	0.000115	0.0017	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTEN—hepatitis B	0.000111	0.00164	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—hepatitis B	0.000105	0.00156	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—hepatitis B	0.000103	0.00153	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GGT1—hepatitis B	9.94e-05	0.00147	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GOT1—hepatitis B	9.94e-05	0.00147	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTEN—hepatitis B	9.86e-05	0.00146	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CDKN1A—hepatitis B	9.41e-05	0.00139	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTEN—hepatitis B	7.89e-05	0.00117	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.43e-05	0.000952	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—TP53—hepatitis B	6.41e-05	0.000948	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKR1B1—hepatitis B	6.32e-05	0.000935	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GGT2—hepatitis B	6.06e-05	0.000896	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—hepatitis B	5.29e-05	0.000782	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTEN—hepatitis B	4.03e-05	0.000597	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP2A6—hepatitis B	3.67e-05	0.000543	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.42e-05	0.000506	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GOT2—hepatitis B	3.32e-05	0.000491	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GGT1—hepatitis B	2.87e-05	0.000424	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GOT1—hepatitis B	2.87e-05	0.000424	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.61e-05	0.000386	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—hepatitis B	1.52e-05	0.000226	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTEN—hepatitis B	1.16e-05	0.000172	CbGpPWpGaD
